Firvanq will replace CutisPharma's FIRST-Vancomycin Unit-of-Use Compounding Kit. CutisPharma announced the availability of Firvanq (vancomycin HCl) for oral solution to treat Clostridium ...
The short-term stability of Adderall in three extemporaneously compounded oral liquids was studied. Three suspensions of Adderall 1 mg/Mc were prepared from commercially available 10-mg Adderall ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO — Compounded oral liquid levothyroxine products vary in stability, potency and consistency and present ...
The FDA on Monday granted approval to CutisPharma's drug Firvanq to treat Clostridium difficile-associated diarrhea and Staphylococcus aureus-associated intestinal inflammation (enterocolitis). Here ...
Oral Vancomycin Solution Kit Launched CutisPharma announced the launch of FIRST Vancomycin oral solution compounding kits for the treatment of Clostridium difficile (C.diff) infection. CutisPharma ...
Adjunct Assistant Professor, Department of Psychiatry, Division of Child and Adolescent Psychiatry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada A ...
CMP Pharma announced its CaroSpir is the first FDA-approved oral liquid dosage form of the potassium-sparing diuretic spironolactone. CaroSpir oral suspension, in a banana flavor, allows adult ...
Scienture Holdings, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved its liquid formulation of losartan, branded as ArbliTM (losartan potassium) Oral Suspension, at a ...
SH-110, a liquid medication for glioma, received FDA orphan drug designation, improving treatment options for patients with swallowing difficulties. Orphan drug status offers incentives such as tax ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results